Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 5
1998 6
1999 1
2000 1
2001 1
2002 4
2003 1
2006 2
2007 2
2008 2
2009 1
2010 1
2011 1
2012 4
2013 2
2014 2
2015 1
2016 3
2017 1
2018 1
2019 1
2020 2
2021 1
2022 3
2023 3
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
The impact of the comorbid seizure/epilepsy on the health related quality of life in people with multiple sclerosis: an international multicentric study.
Drulovic J, Pekmezovic T, Tamas O, Adamec I, Aleksic D, Andabaka M, Basic Kes V, Butkovic Soldo S, Cukic M, Despinic L, Dincic E, Djelilovic Vranic J, Grgic S, Habek M, Hristova SI, Ivanovic J, Jovanovic A, Jovicevic V, Krbot Skoric M, Kuzmanovski I, Maric G, Mesaros S, Milanov IG, Miletic Drakulic S, Sinanovic O, Skarpa Prpic I, Sremec J, Tadic D, Toncev G, Sokic D. Drulovic J, et al. Among authors: dincic e. Front Immunol. 2023 Nov 7;14:1284031. doi: 10.3389/fimmu.2023.1284031. eCollection 2023. Front Immunol. 2023. PMID: 38022568 Free PMC article.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
[Prions and neurodegenerative diseases].
Raicević R, Matković D, Jovicić A, Dujić A, Balint B, Dincić E, Dordević D, Magdić B, Trkuljić M. Raicević R, et al. Among authors: dincic e. Vojnosanit Pregl. 1997 Nov-Dec;54(6):595-605. Vojnosanit Pregl. 1997. PMID: 9481938 Review. Serbian. No abstract available.
[The blood-brain barrier].
Dincić E, Jovicić A, Magdić B, Popović P, Dordević D, Raicević R. Dincić E, et al. Vojnosanit Pregl. 2002 Nov-Dec;59(6):633-41. doi: 10.2298/vsp0206633d. Vojnosanit Pregl. 2002. PMID: 12557622 Review. Serbian. No abstract available.
[The Fahr syndrome].
Raicević R, Jovicić A, Djordjević D, Dincić E, Marković Lj. Raicević R, et al. Among authors: dincic e. Vojnosanit Pregl. 1998 Mar-Apr;55(2):219-23. Vojnosanit Pregl. 1998. PMID: 9623350 Serbian.
[Neurologic aspects of acute intermittent porphyria].
Dincić E, Jovicić A, Djordjević D, Raicević R, Veljancić D. Dincić E, et al. Vojnosanit Pregl. 1998 Jan-Feb;55(1):41-50. Vojnosanit Pregl. 1998. PMID: 9612126 Review. Serbian. No abstract available.
53 results